Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

On-Q-ity Inc.

www.on-q-ity.com

Latest From On-Q-ity Inc.

Device/Diagnostics Quarterly Deal Statistics, Q1 2012

Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.

Medical Device Deals

Medical Device Deals Update, March 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Recent Financings Of Private Companies (03/2012)

START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

BioPharmaceutical Medical Device

Ventana President Mara Aspinall: An Interview With “The Pink Sheet” DAILY

In the midst of a busy January – in which Ventana has signed four publicly disclosed deals to develop companion diagnostics with pharma partners – Ventana President Mara Aspinall talked with “The Pink Sheet” DAILY about pharma’s evolving attitude on personalized medicine, sharing value for joint projects and how Ventana is positioning itself to be the partner of choice for pharma.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • DNA Repair Co.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • On-Q-ity Inc.
  • Senior Management
  • Michael T Stocum, Pres. & CEO
  • Contact Info
  • On-Q-ity Inc.
    Phone: (781) 895-8100
    610 Lincoln St. North Bldg.
    3rd Fl.
    Waltham, MA 02451
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register